H R Alexander

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. pmc Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
    H Richard Alexander
    Divisions of General and Oncologic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Surgery 153:779-86. 2013
  2. ncbi request reprint Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma
    H R Alexander
    Department of Surgery, University of Maryland Medical Center, Baltimore, MD 21201, USA
    Cancer Treat Res 134:343-55. 2007
  3. doi request reprint Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center
    H Richard Alexander
    Department of Surgery, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 16:1852-9. 2009
  4. pmc Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters
    H Richard Alexander
    Department of Surgery, University of Maryland School of Medicine, 22 South Greene St S4B05A, Baltimore, MD 21201, USA
    J Clin Oncol 28:114-8. 2010
  5. doi request reprint Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastases
    H Richard Alexander
    Division of Surgical Oncology, Department of Surgery, and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Cancer J 16:132-41. 2010
  6. ncbi request reprint Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
    D L Bartlett
    Surgery Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Surgery 129:176-87. 2001
  7. ncbi request reprint Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma
    T G Zogakis
    Surgery Branch and the Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA
    Ann Surg Oncol 8:771-8. 2001

Collaborators

Detail Information

Publications8

  1. pmc Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
    H Richard Alexander
    Divisions of General and Oncologic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Surgery 153:779-86. 2013
    ..This study was performed to identify factors associated with long-term outcome...
  2. ncbi request reprint Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma
    H R Alexander
    Department of Surgery, University of Maryland Medical Center, Baltimore, MD 21201, USA
    Cancer Treat Res 134:343-55. 2007
    ..Although not specific for patients with MPM, 2 reports have convincingly demonstrated that HRQOL is significantly improved after HIPEC...
  3. doi request reprint Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center
    H Richard Alexander
    Department of Surgery, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 16:1852-9. 2009
    ....
  4. pmc Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters
    H Richard Alexander
    Department of Surgery, University of Maryland School of Medicine, 22 South Greene St S4B05A, Baltimore, MD 21201, USA
    J Clin Oncol 28:114-8. 2010
    ..027; male:female HR, 1.82; 95% CI, 1.07 to 3.09). CONCLUSION In appropriately selected patients, ILP has clinical benefit. The use of TNF was not associated with improved in-field PFS, while female sex was associated with better survival...
  5. doi request reprint Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastases
    H Richard Alexander
    Division of Surgical Oncology, Department of Surgery, and the Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Cancer J 16:132-41. 2010
    ....
  6. ncbi request reprint Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
    D L Bartlett
    Surgery Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Surgery 129:176-87. 2001
    ..HAI appears to prolong the duration of response after IHP, and this combined treatment strategy deserves additional clinical evaluation as a therapeutic modality in this setting...
  7. ncbi request reprint Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma
    T G Zogakis
    Surgery Branch and the Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA
    Ann Surg Oncol 8:771-8. 2001
    ..In addition, patients who have a CR after ILP and have a history of prior treatment or larger lesions should be considered for adjuvant systemic therapy...